Staphylococcal infection
Drug research and approvals for staphylococcal infection: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 21, 2026, 23 studies of staphylococcal infection are recruiting on ClinicalTrials.gov, and Health Canada has authorized 0 drug trials for it since 2013.
- Recruiting worldwide: 23
- Trials authorized in Canada: 0
- FDA orphan approvals: 0
- EU medicines: 0
- Population Pharmacokinetic Model of Rifampicin in Staphylococcal Osteoarticular InfectionsNCT07788404 · Not applicable · Groupe Hospitalier Diaconesses Croix Saint-Simon · starts Jun 10, 2023
- Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision…NCT07428265 · Not applicable · King Edward Medical University · starts Jan 2, 2026
- Rifampin-free Regimen Versus Rifampin-containing Regimen in the Treatment of Staphylococcal Prosthetic Valve…NCT07345325 · Phase 3 · Nantes University Hospital · starts Jun 11, 2026
- Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisNCT07333378 · Not applicable · Pontificia Universidad Catolica de Chile · starts Sep 29, 2026
- Rifampin-combined Antibiotic Therapy for Staphylococcal PJINCT07313215 · Not applicable · First Affiliated Hospital of Fujian Medical University · starts Nov 13, 2025
- Perspectives on Antibiotics and Tracking Symptoms in ChildrenNCT07093749 · Not applicable · Murdoch Childrens Research Institute · starts Sep 16, 2025
- Linezolid Plus Standard of CareNCT06958835 · Not applicable · University Hospital, Basel, Switzerland · starts Oct 6, 2025
- Unbound Cloxacillin Concentrations During Continuous InfusionNCT06848387 · Phase 4 · Emeli Månsson · starts Jan 14, 2026
- Administering NMT to Reestablish Infant Nasal Microbiome Diversity Following Intranasal Mupirocin TreatmentNCT06805994 · Phase 1 · Johns Hopkins University · starts Aug 27, 2025
How its trials ended
259 ClinicalTrials.gov studies of the condition, classified by TrialPanorama, partly automatically, so some labels are wrongOf the 71 whose ending is known, 45% met their primary endpoint, 13% missed it and 42% stopped early.
- Completed, result not reported12046%
- Status unknown3714%
- Met its primary endpoint3212%
- Ongoing3112%
- Stopped: other or unclear166%
- Stopped: enrollment or feasibility114%
- Missed its primary endpoint93%
- Stopped: lack of efficacy1<1%
- Stopped: safety1<1%
- Stopped: sponsor or business decision1<1%
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA